Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Clinical Trials Related to Axicabtagene Ciloleucel
Related studies linked through entity extraction aliases.
Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Axi-cel in CNS Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Axicabtagene Ciloleucel Expanded Access Study
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2)
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2